|
|
 |
|
Viewing report
|
|
|
|
Prostate Cancer Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., April 2009, Pages: 739
This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Millions. Analytics in the report specifically focuses on revenues generated from hormonal therapies.The report provides separate comprehensive analytics for US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2006 through 2015. The report profiles 138 companies including many key and niche players worldwide such as Abbott Laboratories, Æterna Zentaris Inc., ALZA Corporation, Amgen Inc., AstraZeneca PLC., Medimmune, LLC, Bristol-Myers Squibb Company, Cell Genesys Inc., Dendreon Corporation, EUSA Pharma, (USA) Inc., F. Hoffmann-La Roche Ltd., Genentech Inc., GlaxoSmithKline Plc., Immunomedics, Inc., Indevus Pharmaceuticals Inc., Novartis AG, OSI Pharmaceuticals, Inc., Paladin Labs Inc., Pfizer Inc., Progenics Pharmaceuticals, Inc., Sanofi-Aventis SA, Spectrum Pharmaceuticals, Inc., and Takeda Pharmaceutical Company Limited. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Cancer Prostate Cancer
Analytical Tool - Prostate Cancer
Prostate Cancer Therapeutics - A Global Market Perspective
Prostate Cancer Therapeutics - A Global Market Perspective
Prostate Cancer Drug Pipeline Report
Cancer Therapeutics Markets
Prostate Cancer - A Therapeutic & Competitive Insight
U.S. Emerging Prostate Cancer Therapeutics Markets
Analytical Tool - Prostate Cancer: A Therapeutic & Competitive Insight
Prostate and Breast Cancer- New Treatments & Developmental Progress
Antibody Drug Targets and Focus on Breast & Prostate Cancer
The Prostate Cancer R&D Database
|
|
|
|
